Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial

Luciano, Juan Vicente; D'Amico, Francesco; Cerdà Lafont, Marta; PEÑARRUBIA-MARÍA, M TERESA; Knapp, Martin; Cuesta Vargas, Antonio Ignacio; Serrano Blanco, Antoni; Garcia-Campayo, Javier

Please use this identifier to cite or link to this item: http://hdl.handle.net/10609/92581

Title:	Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial
Author:	Luciano, Juan Vicente D'Amico, Francesco Cerdà Lafont, Marta PEÑARRUBIA-MARÍA, M TERESA Knapp, Martin Cuesta Vargas, Antonio Ignacio Serrano Blanco, Antoni Garcia-Campayo, Javier
Others:	Universidad de Málaga London School of Economics and Political Science Universitat Oberta de Catalunya (UOC)
Citation:	Luciano Devis, J.V., D'Amico, F., Cerdà-Lafont, M., Peñarrubia-María, M.T., Knapp, M., Cuesta-Vargas, A.I., Serrano Blanco, A. & García-Campayo, J. (2014). Cost-utility of cognitive behavioral therapy versus U.S. food and drug administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial. Arthritis Research and Therapy, 16(1). doi: 10.1186/s13075-014-0451-y
Abstract:	Cognitive behavioral therapy (CBT) and U.S. Food and Drug Administration (FDA)-recommended pharmacologic treatments (RPTs; pregabalin, duloxetine, and milnacipran) are effective treatment options for fibromyalgia (FM) syndrome and are currently recommended by clinical guidelines. We compared the cost-utility from the healthcare and societal perspectives of CBT versus RPT (combination of pregabalin + duloxetine) and usual care (TAU) groups in the treatment of FM.
Keywords:	cognitive behavioral therapy usual care fibromyalgia pregabalin duloxetine
DOI:	10.1186/s13075-014-0451-y
Document type:	info:eu-repo/semantics/article
Version:	info:eu-repo/semantics/publishedVersion
Issue Date:	1-Oct-2014
Publication license:	http://creativecommons.org/licenses/by/3.0/es/
Appears in Collections:	Articles Articles cientÍfics